Scholar

Neeraj Lal

Google Scholar ID: UgU0vfEAAAAJ

University of Birmingham

Cancer ImmunologyColorectal Cancer

Citations & Impact

All-time

Citations

890

H-index

i10-index

Publications

Co-authors

list available

Contact

Publications

1 items

2025

Cited

Resume (English only)

Academic Achievements

- Publications: Multiple high-impact publications in journals such as Scientific Data, British Journal of Cancer, and Cancer Research Communications.
- Funding: Held current and previous research funding from the National Institute of Health and Care Research, Cancer Research UK, the Medical Research Council, and the Royal College of Surgeons (England).

Research Experience

- Completed core surgical training and then undertook a Cancer Research UK-funded PhD at the University of Birmingham.
- Appointed as an NIHR Academic Clinical Lecturer in Professor Andrew Beggs' group and the Academic Department of Surgery to further develop his work in the field of immunogenomics with the aim of successfully applying immunotherapeutics in colorectal cancer.
- Currently focused on the development and application of cancer organoid and immune cell co-culture models to identify and investigate novel targets for cancer immunotherapies.
- Co-investigator on the ORB-AZ and Target ID studies, as well as the ROSSINI II Randomised Clinical Trial.

Education

- PhD in Cancer Sciences (University of Birmingham)
- Supervisors: Professor Willcox, Professor Gary Middleton, Professor Chris Tselepis
- MRCS (England)
- MBBS
- BSc in Neuroscience

Background

- Research Interests: Immunogenomics of colorectal cancer, developing new immunotherapeutic strategies
- Professional Fields: Cancer immunology, cancer genetics and genomics, bioinformatics, organoid models
- Biography: Mr Neeraj Lal is an Academic Clinical Lecturer in General Surgery at the Department of Applied Health Sciences, University of Birmingham. His major research interest is in the immunogenomics of colorectal cancer, with the aim of developing new immunotherapeutic strategies in this common cancer type.

Miscellany